Objective: Aspirin exhibits anti-atherosclerotic and anti-inflammatory properties—two potential risk factors for depression. The relationship between aspirin use and depression, however, remains unclear. We investigated whether the aspirin use is associated with a decreased incidence of depressive symptoms in a large North American cohort. Methods: Data from the Osteoarthritis Initiative dataset, a multicenter, longitudinal study on community-dwelling adults was analyzed. Aspirin use was defined through self-report in the past 30 days and confirmed by a trained interviewer. Incident depressive symptoms were defined as a score of ≥16 in the 20-item Center for Epidemiologic Studies-Depression scale. Results: A total of 137 participants (mean age 65 y, 55.5% female) were using aspirin at baseline. Compared with 4003 participants not taking aspirin, no differences in Center for Epidemiologic Studies-Depression at baseline were evident (P =.65). After a median follow-up time of 8 years, the incidence of depressive symptoms was similar in those taking aspirin at baseline (43; 95% CI, 3-60) and in aspirin nonusers (38; 95% CI, 36-41) per 1000 y; log-rank test = 0.63). Based on Cox's regression analysis adjusted for 11 potential confounders, aspirin use was not significantly associated with the development of depressive symptoms (hazard ratio = 1.12; 95% CI, 0.78-1.62; P =.54). Adjustment for propensity scores or the use of propensity score matching did not alter the results. Conclusion: Our study found that prescription of aspirin offered no significant protection against incident depressive symptoms. Whether aspirin is beneficial in a subgroup of depression with high levels of inflammation remains to be investigated in future studies. Copyright © 2017 John Wiley & Sons, Ltd.

Veronese, N., Koyanagi, A., Stubbs, B., Solmi, M., Fornaro, M., Fernandes, B., et al. (2018). Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33(2), e193-e198 [10.1002/gps.4767].

Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years

Veronese, N.
;
2018-01-01

Abstract

Objective: Aspirin exhibits anti-atherosclerotic and anti-inflammatory properties—two potential risk factors for depression. The relationship between aspirin use and depression, however, remains unclear. We investigated whether the aspirin use is associated with a decreased incidence of depressive symptoms in a large North American cohort. Methods: Data from the Osteoarthritis Initiative dataset, a multicenter, longitudinal study on community-dwelling adults was analyzed. Aspirin use was defined through self-report in the past 30 days and confirmed by a trained interviewer. Incident depressive symptoms were defined as a score of ≥16 in the 20-item Center for Epidemiologic Studies-Depression scale. Results: A total of 137 participants (mean age 65 y, 55.5% female) were using aspirin at baseline. Compared with 4003 participants not taking aspirin, no differences in Center for Epidemiologic Studies-Depression at baseline were evident (P =.65). After a median follow-up time of 8 years, the incidence of depressive symptoms was similar in those taking aspirin at baseline (43; 95% CI, 3-60) and in aspirin nonusers (38; 95% CI, 36-41) per 1000 y; log-rank test = 0.63). Based on Cox's regression analysis adjusted for 11 potential confounders, aspirin use was not significantly associated with the development of depressive symptoms (hazard ratio = 1.12; 95% CI, 0.78-1.62; P =.54). Adjustment for propensity scores or the use of propensity score matching did not alter the results. Conclusion: Our study found that prescription of aspirin offered no significant protection against incident depressive symptoms. Whether aspirin is beneficial in a subgroup of depression with high levels of inflammation remains to be investigated in future studies. Copyright © 2017 John Wiley & Sons, Ltd.
Veronese, N., Koyanagi, A., Stubbs, B., Solmi, M., Fornaro, M., Fernandes, B., et al. (2018). Aspirin and incident depressive symptoms: A longitudinal cohort study over 8 years. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 33(2), e193-e198 [10.1002/gps.4767].
File in questo prodotto:
File Dimensione Formato  
nihms930641.pdf

Solo gestori archvio

Tipologia: Post-print
Dimensione 117.33 kB
Formato Adobe PDF
117.33 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
gps.4767.pdf

Solo gestori archvio

Tipologia: Versione Editoriale
Dimensione 114.71 kB
Formato Adobe PDF
114.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/464682
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 8
social impact